This bill amends Minnesota Statutes 2024, section 62Q.481, subdivision 2, to include epilepsy as a recognized chronic disease, thereby expanding the definition of chronic diseases to encompass diabetes, asthma, and epilepsy. Additionally, the bill clarifies the definition of "related medical supplies" to include items necessary for the treatment of epilepsy alongside other chronic diseases.

Furthermore, the bill introduces a provision that limits cost-sharing for epilepsy-related prescription drugs and medical supplies, ensuring that individuals with epilepsy have more affordable access to necessary treatments. The new legal language specifies that these changes will take effect on January 1, 2027, and will apply to health plans that are offered, issued, or renewed on or after that date.

Statutes affected:
Introduction: 62Q.481